Is progression of arteriosclerosis in ESRD patients inhibited by nocturnal hemodialysis of renal transplantation?

Is progression of arteriosclerosis in ESRD patients inhibited by nocturnal hemodialysis of renal transplantation? - Nocturnal hemodialysis and arteriosclerosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47285

Enrollment

180

Registered

2008-12-16

Start date

2009-12-16

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease in hemodialysis patients

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. patients who start with nocturnal home hemodialysis 2. patients who undergo an renal transplant from a living donor 3. patients treated with conventional hemodialysis 4. patients treated with peritoneal dialysis NB patients aged 18-80 yr are included

Exclusion criteria

Exclusion criteria: - life expectancy

Design outcomes

Primary

Measure	Time frame
- individual change in coronary artery calcification score	—

Secondary

Measure	Time frame
- individual change in pulse wave velocity - change in in calcification score in aorta and iliac arteries - change in coronary stenosis and left ventricular function - association between calciumphosphate homeostasis, inflammatory parameters and calcification inhibitors on the one hand and change in coronary artery calcification score on the other hand	—

Countries

Netherlands

Outcome results